Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis. (Q39405773)
Jump to navigation
Jump to search
scientific article published on 11 May 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis. |
scientific article published on 11 May 2013 |
Statements
Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis (English)
Paul P Tak
Geesje M Dallinga-Thie
Aart C Strang
Radjesh J Bisoendial
Ruud S Kootte
Dominik M Schulte
Johannes H M Levels
Koen Vos
Sander W Tas
Uwe J F Tietge
Nike Müller
Matthias Laudes
Danielle M Gerlag